ARTIFICIAL SWEETENERS - AS SAFE AS THEY SEEM? IMPACTS ON GUT MICROBIOTA, METABOLISM, INFLAMMATION, CARDIOVASCULAR HEALTH AND SPORTS PERFORMANCE - A LITERATURE REVIEW
Abstract
For a considerable length of time, artificial sweeteners have been seen as safe dietary ingredients, promoting weight control and regulating blood sugar levels. However, a growing number of scientific studies are questioning their supposed biological neutrality. Current analyses suggest that some of these substances may affect the composition and function of the gut microbiota, which in turn may affect the immune system and play a role in the development of chronic inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. There is growing evidence of a potential link between long-term intake of artificial sweeteners and the onset of insulin resistance and type 2 diabetes. In addition, it has been noted that frequent consumption of artificially sweetened beverages may be associated with an increased risk of stroke, cardiovascular disease and higher overall mortality, especially among overweight or obese postmenopausal women. These substances are commonly used in protein supplements, energy drinks and sports supplements, which may also affect important post-exercise recovery processes - including inflammation, insulin regulation, gut function and hydration status. These observations highlight the need for further interdisciplinary research into the long-term effects of artificial sweeteners on metabolic health and overall body function, especially in groups with high levels of consumption, such as people with metabolic syndrome and patients with type 2 diabetes.
References
Kossiva, L., Kakleas, K., Christodouli, F., Soldatou, A., Karanasios, S., & Karavanaki, K. (2024). Chronic use of artificial sweeteners: Pros and cons. Nutrients, 16(18), 3162. https://doi.org/10.3390/nu16183162
Iizuka, K. (2022). Is the use of artificial sweeteners beneficial for patients with diabetes mellitus? The advantages and disadvantages of artificial sweeteners. Nutrients, 14(21), 4446. https://doi.org/10.3390/nu14214446
Debras, C., Chazelas, E., Srour, B., Druesne-Pecollo, N., Esseddik, Y., Szabo de Edelenyi, F., Agaesse, C., De Sa, A., Lutchia, R., Gigandet, S., et al. (2022). Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. PLOS Medicine, 19, e1003950. https://doi.org/10.1371/journal.pmed.1003950
Tsan, L., Chometton, S., Hayes, A. M., Klug, M. E., Zuo, Y., Sun, S., Bridi, L., Lan, R., Fodor, A. A., Noble, E. E., et al. (2022). Early-life low-calorie sweetener consumption disrupts glucose regulation, sugar-motivated behavior, and memory function in rats. JCI Insight, 7, e157714. https://doi.org/10.1172/jci.insight.157714
Mossavar-Rahmani, Y., Kamensky, V., Manson, J. E., Silver, B., Rapp, S. R., Haring, B., Beresford, S. A. A., Snetselaar, L., & Wassertheil-Smoller, S. (2019). Artificially sweetened beverages and stroke, coronary heart disease, and all-cause mortality in the Women’s Health Initiative. Stroke, 50(2), 555–562. https://doi.org/10.1161/STROKEAHA.118.023100
O’Callaghan, A., & van Sinderen, D. (2016). Bifidobacteria and their role as members of the human gut microbiota. Frontiers in Microbiology, 7, 925. https://doi.org/10.3389/fmicb.2016.00925
Mirsepasi-Lauridsen, H. C., Vallance, B. A., Krogfelt, K. A., & Petersen, A. M. (2019). Escherichia coli pathobionts associated with inflammatory bowel disease. Clinical Microbiology Reviews, 32(4), e00060-18. https://doi.org/10.1128/CMR.00060-18
Usuda, H., Okamoto, T., & Wada, K. (2021). Leaky gut: Effect of dietary fiber and fats on microbiome and intestinal barrier. International Journal of Molecular Sciences, 22(14), 7613. https://doi.org/10.3390/ijms22147613
Rodriguez-Palacios, A., Harding, A., Menghini, P., Himmelman, C., Retuerto, M., Nickerson, K. P., Lam, M., Croniger, C. M., McLean, M. H., Durum, S. K., et al. (2018). The artificial sweetener Splenda promotes gut Proteobacteria, dysbiosis, and myeloperoxidase reactivity in Crohn's disease-like ileitis. Inflammatory Bowel Diseases, 24(5), 1005–1020. https://doi.org/10.1093/ibd/izy060
Rios-Leyvraz, M., & Montez, J. (2022). Health effects of the use of non-sugar sweeteners: A systematic review and meta-analysis. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240046429
Qin, P., Li, Q., Zhao, Y., et al. (2020). Sugar and artificially sweetened beverages and risk of obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality: A dose-response meta-analysis of prospective cohort studies. European Journal of Epidemiology, 35(7), 655–671.
Azad, M. B., Abou-Setta, A. M., Chauhan, B. F., et al. (2017). Nonnutritive sweeteners and cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. CMAJ, 189(28), E929–E939.
Qin, J., Li, Y., Cai, Z., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 490(7418), 55–60.
Chi, L., Bian, X., Gao, B., Tu, P., Lai, Y., Ru, H., & Lu, K. (2018). Effects of the artificial sweetener Neotame on the gut microbiome and fecal metabolites in mice. Molecules, 23(2), 367. https://doi.org/10.3390/molecules23020367
Liu, L., Yang, M., Dong, W., Liu, T., Song, X., Gu, Y., et al. (2021). Gut dysbiosis and abnormal bile acid metabolism in colitis-associated cancer. Gastroenterology Research and Practice, 2021, 6645970.
Tsuei, J., Chau, T., Mills, D., & Wan, Y.-J. Y. (2014). Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Experimental Biology and Medicine, 239(11), 1489–1504.
Hanawa, Y., Higashiyama, M., Kurihara, C., Tanemoto, R., Ito, S., Mizoguchi, A., et al. (2021). Acesulfame potassium induces dysbiosis and intestinal injury with enhanced lymphocyte migration to intestinal mucosa. Journal of Gastroenterology and Hepatology, 36(11), 3140–3148. https://doi.org/10.1111/jgh.15654
M., & Vellapandian, C. (2024). Exploring the long-term effect of artificial sweeteners on metabolic health. Cureus, 16(9), e70043. https://doi.org/10.7759/cureus.70043
Ruiz-Ojeda, F. J., Plaza-Díaz, J., Sáez-Lara, M. J., & Gil, A. (2019). Effects of sweeteners on the gut microbiota: A review of experimental studies and clinical trials. Advances in Nutrition, 10(suppl_1), S31–S48. https://doi.org/10.1093/advances/nmy037
Angelin, M., Kumar, J., Vajravelu, L. K., Satheesan, A., Chaithanya, V., & Murugesan, R. (2024). Artificial sweeteners and their implications in diabetes: A review. Frontiers in Nutrition, 11, 1411560. https://doi.org/10.3389/fnut.2024.1411560
Debras, C., Deschasaux-Tanguy, M., Chazelas, E., et al. (2023). Artificial sweeteners and risk of type 2 diabetes in the prospective NutriNet-Santé cohort. Diabetes Care, 46(9), 1681–1690. https://doi.org/10.2337/dc23-0206
Suez, J., Cohen, Y., Valdés-Mas, R., et al. (2022). Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell, 185(18), 3307–3328.e19.
Fagherazzi, G., Gusto, G., Affret, A., Mancini, F. R., Dow, C., Balkau, B., et al. (2017). Chronic consumption of artificial sweetener in packets or tablets and type 2 diabetes risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition Study. Annals of Nutrition and Metabolism, 70(1), 51–58. https://doi.org/10.1159/000458769
Shon, W. J., Jung, M. H., Kim, Y., Kang, G. H., Choi, E. Y., & Shin, D. M. (2023). Sugar-sweetened beverages exacerbate high-fat diet-induced inflammatory bowel disease by altering the gut microbiome. Journal of Nutritional Biochemistry, 113, 109254. https://doi.org/10.1016/j.jnutbio.2022.109254
Azad, M. A. K., Sarker, M., Li, T., & Yin, J. (2018). Probiotic species in the modulation of gut microbiota: An overview. BioMed Research International, 2018, 9478630.
Richardson, I. L., & Frese, S. A. (2022). Non-nutritive sweeteners and their impacts on the gut microbiome and host physiology. Frontiers in Nutrition, 9, 988144. https://doi.org/10.3389/fnut.2022.988144
Wołyniec, W., Szwarc, A., Kasprowicz, K., Zorena, K., Jaskulak, M., Renke, M., & Ratkowski, W. (2022). Impact of hydration with beverages containing free sugars or xylitol on metabolic and acute kidney injury markers after physical exercise. Frontiers in Physiology, 13, 841056. https://doi.org/10.3389/fphys.2022.841056
Teysseire, F., Bordier, V., Beglinger, C., Wölnerhanssen, B. K., & Meyer-Gerspach, A. C. (2024). Metabolic effects of selected conventional and alternative sweeteners: A narrative review. Nutrients, 16(5), 622. https://doi.org/10.3390/nu16050622
Stellingwerff, T., Godin, J. P., Beaumont, M., Tavenard, A., Grathwohl, D., van Bladeren, P. J., et al. (2013). Effects of pre-exercise sucralose ingestion on carbohydrate oxidation during exercise. International Journal of Sport Nutrition and Exercise Metabolism, 23(6), 584–592. https://doi.org/10.1123/ijsnem.23.6.584
Painelli, V. S., Fernandes, E., & Brietzke, C. (2023). The placebo effect of a pink non-caloric, artificially sweetened solution on strength endurance performance and psychological responses in trained individuals. Nutrition and Health, 29(3), 233–243. https://doi.org/10.1177/02601060231196590
Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., et al. (2018). Environment dominates over host genetics in shaping human gut microbiota. Nature, 555(7695), 210–215.
Hills, R. D., Pontefract, B. A., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2019). Gut microbiome: Profound implications for diet and disease. Nutrients, 11(7), 1613.
Views:
6
Downloads:
0
Copyright (c) 2025 Monika Grudzień, Aleksandra Nowińska, Anna Gryc, Jakub Lipiec, Aleksandra Gradek, Marcin Sawczuk, Dominika Nowak, Kamil Nieroda, Wojciech Urban, Miłosz Szczotka
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
